Navigation Links
Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever
Date:9/9/2009

nd is dedicated to providing innovative products which improve quality of care for patients. The Company recently completed the initial public offering of its common stock.

For more information on Cumberland Pharmaceuticals, please visit www.cumberlandpharma.com.

About Caldolor

Caldolor is indicated for the management of mild to moderate pain and management of moderate to severe pain as an adjunct to opioid analgesics, and for the reduction of fever in adults. It is the first FDA approved intravenous therapy for fever. Caldolor is contraindicated in patients with known hypersensitivity to ibuprofen or other NSAIDs, patients with asthma, urticaria, or allergic type reactions after taking aspirin or other NSAIDs. Caldolor is contraindicated for use during the peri-operative period in the setting of coronary artery bypass graft (CABG) surgery. Caldolor should be used with caution in patients with prior history of ulcer disease or GI bleeding, in patients with fluid retention or heart failure, in the elderly, those with renal impairment, heart failure, liver impairment, and those taking diuretics or ACE inhibitors. Blood pressure should be monitored during treatment with Caldolor. For full prescribing information, visit www.caldolor.com.

About Acetadote

Acetadote is used in the emergency department to prevent or lessen potential liver damage resulting from an overdose of acetaminophen, a common ingredient in many over-the-counter painkillers. It is the only approved injectable product in the United States for the treatment of acetaminophen overdose, the leading cause of poisonings presenting in emergency departments in the country(1). Acetadote is contraindicated in patients with
'/>"/>

SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Orion ICG, LLC Announces Acquisition of Cumberland Therapy Services, Inc.
2. Cumberland Pharmaceuticals Announces Appointments
3. Cumberland Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 27, 2009
4. Cumberland Pharmaceuticals Reports Second Quarter 2009 Financial Results
5. Cumberland Pharmaceuticals to Present at UBS Global Life Sciences Conference in New York on September 21, 2009
6. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
7. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
10. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
11. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... Texas (PRWEB) June 01, 2015 Unlike most ... as three times for in-use periods compared to when the ... monthly rate whether the client uses the generator or not. ... availability and delivery in as little as a few hours ... desire to store a portable generator onsite. , “Even minor ...
(Date:6/1/2015)... On May 14, 2015, the ... the Cherry Creek Chamber of Commerce for the grand ... centers typically do not offer primary care services by ... Creek Urgent Care staff to schedule family care procedures, ... to 7:30 p.m. the center hosted presidents, CEOs, and ...
(Date:6/1/2015)... June 01, 2015 Sharenote, a leading ... for the Healthcare Industry this week in Louisiana. The ... in four days to provide potential providers with the ... profitability, and monitor risk within their network. , ... and is being used by more than 250 practices. ...
(Date:6/1/2015)... There’s never a good time to be ... non-emergency, minor illnesses. , As of June 1, OSF HealthCare ... medical care via the Internet. Patients throughout Illinois can access ... , “Everyone is busy. We know that getting in to ... want to make it easier,” said Jeffry Tillery, MD, Chief ...
(Date:6/1/2015)... Hexagon Geospatial is pleased to announce the launch ... service that provides on-demand access to the company’s world-class ... IMAGINE and GeoMedia are now available ... subscription model for delivering software products as an online ... quickly and easily access the right tools that help ...
Breaking Medicine News(10 mins):Health News:Worldwide Power Products Offers “Budget Billing” Contingency Generator Rental Program; Guarantees Power for Peak of Hurricane Season and Beyond 2Health News:Grand Opening For AFC/Doctors Express Cherry Creek Primary Care Clinic 2Health News:OSF HealthCare Now Offering OSF OnCall 2Health News:OSF HealthCare Now Offering OSF OnCall 3Health News:Hexagon Geospatial Launches Cloud-Based Producer Online Suite 2Health News:Hexagon Geospatial Launches Cloud-Based Producer Online Suite 3
... the drug Tamiflu to avert the bird flu outbreak ... February 2006//. ,Scientists at the High Security ... and genetic analysis of virus collected from Jalgaon and ... to Tamiflu due the different types of amino acids ...
... Integrated Counselling and Testing Centres at Government General Hospitals ... with the Indian Public Health Standards (IPHS), draft guidelines ... aim to spread awareness about AIDS in the susceptible ... 2006 report on the global AIDS epidemic, 486 fresh ...
... month, The Medicines and Healthcare products Regulatory Agency ... amendment it is now possible to market homoeopathic ... and therapeutic application of remedies in question. This ... who have written off homoeopathy as ‘mumbo jumbo’ ...
... from Drexel University and the University of Brighton in ... improve the treatment of sepsis. // ... or severe trauma that results in 1,500 deaths worldwide ... lung and breast cancers. Sepsis occurs when proteins called ...
... Jude Children's Research Hospital have discovered in mouse models ... earliest critical regulators // controlling lens development in the ... have been previously identified in patients with holoprosencephaly, a ... called the cerebrum to fail to divide normally into ...
... of cognitive decline experienced by several cancer patients receiving ... on the // effect of chemotherapy on cognitive functions ... Baycrest Research Centre for Aging and the Brain carried ... Drs. Ian Tannock and Janette Vardy of Princess Margaret ...
Cached Medicine News:Health News:Bird flu outbreak prevented by Tamiflu 2Health News:Anti-HIV drive intensified in Haryana 2Health News:Hostility breeds against Homeopathy in England following new regulations 2Health News:Drexel Research in Cytokines Could Treat Sepsis 2Health News:Key Gene Controlling Eye Lens Development Identified 2Health News:Chemo drugs cause cognitive decline in breast cancer patients 2
(Date:6/1/2015)... 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) ... focus on Omega-3 therapies for cardiovascular disease (CVD) ... financial results for the three months ended March ... in Canadian dollars unless otherwise stated. ... despite its limited financial resources," stated Mr. ...
(Date:6/1/2015)... 2015 The nuclear imaging market is estimated ... CAGR of 12.08%. Nuclear medicine is the use of ... types of Nuclear imaging used commonly are PET and ... for nuclear medicine applications like nuclear cardiology procedures. However, ... global shortage of molybdenum-99 isotope which is in turn ...
(Date:6/1/2015)... Nevro Corp. (NYSE: NVRO ), a ... solutions for the treatment of chronic pain, today announced ... its common stock consisting of 1,475,506 shares to be ... by certain of its stockholders. In addition, Nevro expects ... up to an additional 590,202 shares of common stock ...
Breaking Medicine Technology:Pivotal Therapeutics Announces First Quarter Financial Results 2Pivotal Therapeutics Announces First Quarter Financial Results 3Pivotal Therapeutics Announces First Quarter Financial Results 4Pivotal Therapeutics Announces First Quarter Financial Results 5North America Nuclear Imaging Market - Growth, Trends And Forecasts (2014 - 2019) 2North America Nuclear Imaging Market - Growth, Trends And Forecasts (2014 - 2019) 3Nevro Announces Proposed Public Offering of Common Stock 2Nevro Announces Proposed Public Offering of Common Stock 3
... Mich., Jan. 20, 2011 Perrigo Company (Nasdaq: PRGO; ... agreement to acquire substantially all of the assets of ... marketer of generic pharmaceutical products for approximately $540 million ... benefit as a result of the acquisition of Paddock,s ...
... Reportlinker.com announces that a new market research report ... Hospital Radiography & Fluoroscopy Census ... the most comprehensive European market report on the ... Mammography, R&F, Angiography, CT, MRI,) and radiology IT ...
Cached Medicine Technology:Perrigo to Acquire Assets of Paddock Labs for $540 Million 2Perrigo to Acquire Assets of Paddock Labs for $540 Million 3Perrigo to Acquire Assets of Paddock Labs for $540 Million 4Perrigo to Acquire Assets of Paddock Labs for $540 Million 5Reportlinker Adds Hospital Radiography & Fluoroscopy Census 2
The new ProteomeX Workstation enables the rapid set up, execution and analysis of multidimensional LC/MS methods, providing you with the best possible technique to characterize your complex proteomic...
Storage temperature: 2 - 8C, linearity: 0 - 700 mg/dL, expected values: 30 - 780 mg/dL. Available with calibrator and number of tests 110....
Alkaline phosphatase FS (DGKC new; 37C). For determination of alkaline phosphatase (ALP) in serum or plasma. For Hitachi 717. Controls: Trulab N and Trulab P....
For the direct colorimetric determination of alkaline phosphatase in human serum....
Medicine Products: